共 12 条
[1]
Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study. Loyd-Jones DM,Evans JC,Larson MG,et al. Archives of Internal Medicine . 1999
[2]
Fifty years of Framingham study contributions to un-derstanding hypertension. Kannel WB. Journal of Human Hypertension . 2000
[3]
Improved blood pressure control in hypertensive patients treated with statins. Borghi C,Gaddi A,Ambrosioni E. Journal of the American College of Cardiology . 2002
[4]
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hy-pertension and dyslipidemia:results of the AVALON trial. Messerli FH,Bakris GL,Ferrera D,et al. J Clin Hypertens(Greenwich) . 2006
[5]
Major outcome in moderate hypercholes-terolemic hypertensive patients randomized to pravastatin vs usual care:the Antihypertensive and Lipid-lowering Treatment to Pre-vent Heart Attack Trial(ALLHA-LLT). The ALLHATOfficers and Coordinators for the ALLHATCollabo-rative Research Group. The Journal of The American Medical Association . 2002
[6]
Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats,via pleiotropic effects. Yamamoto E,Yamashita T,Tanaka T,et al. Arteriosclerosis and Thrombosis . 2007
[7]
Ethnic and sex differ-ences in the prevalence,treatment,and control of dyslipidemia a-mong hypertensive adults in the GENOA study. O Meara JG,Kardia SLR,Armon JJ,et al. Archives of Internal Medicine . 2004
[8]
Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation:studies in hypercholesterolemic and hypertensive patients. Hussein O,Shneider J,Rosenblat M,et al. Journal of Cardiovascular Pharmacology . 2002
[9]
MRC/BHF Heart Pro-tection Study of cholesterol lowering with simvastatin in20,536high-risk individuals:a randomised placebo-controlled trial. Heart Protection Study Collaborative Group. The Lancet . 2002
[10]
Preventing coronary events by optimal control of blood pressure and lipids in patients with the met-abolic syndrome. Wong ND,Pio JR,Franklin SS,et al. The American Journal of Cardiology . 2003